Calcium Stearate

Calcium stearate
Reference electrode : silver-silver chloride.

Carry out the measurements on the test solution, then add at
least 3 quantities, each of 0.5 mL, of the reference solution,
carrying out a measurement after each addition. Calculate the
concentration of uorides using the calibration curve, taking
into account the addition of uoride to the test solution.
Sulfates (2.4.13) : maximum 0.5 per cent.
Dilute 1 mL of solution S to 25 mL with distilled water R.
Arsenic (2.4.2, Method A) : maximum 4 ppm, determined on
5 mL of solution S.
Iron (2.4.9) : maximum 400 ppm.
Dilute 0.5 mL of solution S to 10 mL with water R.
Heavy metals (2.4.8) : maximum 30 ppm.
Dilute 13 mL of solution S to 20 mL with water R. 12 mL of the
solution complies with test A. Prepare the reference solution
using lead standard solution (1 ppm Pb) R.
Acid-insoluble matter: maximum 0.2 per cent.
Dissolve 5.0 g in a mixture of 10 mL of hydrochloric acid R
and 30 mL of water R. Filter, wash the residue with water R
and dry to constant mass at 100-105 C. The residue weighs
a maximum of 10 mg.
Loss on ignition : maximum 8.0 per cent, determined on
1.000 g by ignition at 800 50 C for 30 min.
EUROPEAN PHARMACOPOEIA 8.0
Content :
calcium : 6.4 per cent to 7.4 per cent (Ar 40.08) (dried
substance) ;
stearic acid in the fatty acid fraction : minimum 40.0 per
cent ;
sum of stearic acid and palmitic acid in the fatty acid
fraction : minimum 90.0 per cent.
CHARACTERS
Appearance : ne, white or almost white, crystalline powder.
Solubility : practically insoluble in water and in ethanol (96 per
cent).
IDENTIFICATION
First identification : C, D.
Second identification : A, B, D.
A. Freezing point (2.2.18) : minimum 53 C, for the residue
obtained in the preparation of solution S (see Tests).
B. Acid value (2.5.1) : 195 to 210.
Dissolve 0.200 g of the residue obtained in the preparation
of solution S in 25 mL of the prescribed mixture of solvents.
C. Examine the chromatograms obtained in the test for fatty
acid composition.
Results : the retention times of the principal peaks in
ASSAY
the chromatogram obtained with the test solution are
approximately the same as those of the principal peaks in
Dissolve 0.200 g in a mixture of 1 mL of hydrochloric acid R1
the chromatogram obtained with the reference solution.
and 5 mL of water R. Add 25.0 mL of 0.1 M sodium edetate
and dilute to 200 mL with water R. Adjust to about pH 10 with D. Neutralise 5 mL of solution S to red litmus paper R using
concentrated ammonia R. Add 10 mL of ammonium chloride
strong sodium hydroxide solution R. The solution gives
buffer solution pH 10.0 R and a few milligrams of mordant
reaction (b) of calcium (2.3.1).
black 11 triturate R. Titrate the excess sodium edetate with
0.1 M zinc sulfate until the colour changes from blue to violet. TESTS
1 mL of 0.1 M sodium edetate is equivalent to 4.008 mg of Ca. Solution S. To 5.0 g add 50 mL of peroxide-free ether R, 20 mL
of dilute nitric acid R and 20 mL of distilled water R. Boil
FUNCTIONALITY-RELATED CHARACTERISTICS
under a reux condenser until dissolution is complete. Allow
This section provides information on characteristics that are
to cool. In a separating funnel, separate the aqueous layer
recognised as being relevant control parameters for one or
and shake the ether layer with 2 quantities, each of 5 mL,
more functions of the substance when used as an excipient (see of distilled water R. Combine the aqueous layers, wash with
chapter 5.15). This section is a non-mandatory part of the
15 mL of peroxide-free ether R and dilute the aqueous layer to
monograph and it is not necessary to verify the characteristics
50 mL with distilled water R (solution S). Evaporate the ether
to demonstrate compliance. Control of these characteristics can layer to dryness and dry the residue at 100-105 C. Keep the
however contribute to the quality of a medicinal product by
residue for identication tests A and B.
improving the consistency of the manufacturing process and
Acidity or alkalinity. To 1.0 g add 20 mL of carbon
the performance of the medicinal product during use. Where
control methods are cited, they are recognised as being suitable dioxide-free water R and boil for 1 min with continuous
for the purpose, but other methods can also be used. Wherever shaking. Cool and lter. To 10 mL of the ltrate add 0.05 mL
of bromothymol blue solution R1. Not more than 0.5 mL
results for a particular characteristic are reported, the control
of 0.01 M hydrochloric acid or 0.01 M sodium hydroxide is
method must be indicated.
required to change the colour of the indicator.
The following characteristics may be relevant for calcium
Chlorides (2.4.4): maximum 0.1 per cent.
phosphate is used as a filler in tablets and capsules.
Dilute 0.5 mL of solution S to 15 mL with water R.
Particle-size distribution (2.9.31 or 2.9.38).
Sulfates (2.4.13) : maximum 0.3 per cent.
Bulk and tapped density (2.9.34).
Dilute 0.5 mL of solution S to 15 mL with distilled water R.
Powder ow (2.9.36).
Cadmium : maximum 3 ppm.
07/2010:0882 Atomic absorption spectrometry (2.2.23, Method II).
corrected 7.0 Test solution. Place 50.0 mg in a polytetrauoroethylene
digestion bomb and add 0.5 mL of a mixture of 1 volume of
CALCIUM STEARATE
hydrochloric acid R and 5 volumes of cadmium- and lead-free
nitric acid R. Allow to digest at 170 C for 5 h. Allow to cool.
Dissolve the residue in water R and dilute to 5.0 mL with the
Calcii stearas
same solvent.
[1592-23-0]
Reference solutions. Prepare the reference solutions using
cadmium standard solution (10 ppm Cd) R, diluted if necessary
DEFINITION
with a 1 per cent V/V solution of hydrochloric acid R.
Mixture of calcium salts of different fatty acids consisting
Source : cadmium hollow-cathode lamp.
mainly of stearic (octadecanoic) acid [(C17H35COO)2Ca ;
Mr 607] and palmitic (hexadecanoic) acid [(C15H31COO)2Ca ; Wavelength : 228.8 nm.
Atomisation device : graphite furnace.
Mr 550.9] with minor proportions of other fatty acids.
1750
See the information section on general monographs (cover pages)
Calcium sulfate dihydrate
EUROPEAN PHARMACOPOEIA 8.0
Lead : maximum 10 ppm.
Temperature :
Atomic absorption spectrometry (2.2.23, Method II).

Test solution. Use the solution described in the test for
cadmium.
Reference solutions. Prepare the reference solutions using lead
standard solution (10 ppm Pb) R, diluted if necessary with
water R.
Source : lead hollow-cathode lamp.
Wavelength : 283.3 nm ; 217.0 nm may be used depending on
the apparatus.
Nickel : maximum 5 ppm.
Atomic absorption spectrometry (2.2.23, Method II).
Test solution. Use the solution described in the test for
cadmium.
Reference solutions. Prepare the reference solutions using
nickel standard solution (10 ppm Ni) R, diluted if necessary
with water R.
Source : nickel hollow-cathode lamp.
Wavelength : 232.0 nm.
Loss on drying (2.2.32): maximum 6.0 per cent, determined
on 1.000 g by drying in an oven at 105 C.
Microbial contamination
TAMC : acceptance criterion 103 CFU/g (2.6.12).
TYMC : acceptance criterion 102 CFU/g (2.6.12).
Absence of Escherichia coli (2.6.13).
Absence of Salmonella (2.6.13).
ASSAY
Calcium. To 0.500 g in a 250 mL conical ask add 50 mL
of a mixture of equal volumes of anhydrous ethanol R
and butanol R, 5 mL of concentrated ammonia R, 3 mL of
ammonium chloride buffer solution pH 10.0 R, 30.0 mL
of 0.1 M sodium edetate and 15 mg of mordant black 11
triturate R. Heat to 45-50 C until the solution is clear. Cool
and titrate with 0.1 M zinc sulfate until the colour changes
from blue to violet. Carry out a blank titration.
1 mL of 0.1 M sodium edetate is equivalent to 4.008 mg of Ca.
Composition of fatty acids. Gas chromatography (2.2.28) :
use the normalisation procedure.
Test solution. In a conical ask tted with a reux condenser,
dissolve 0.10 g of the substance to be examined in 5 mL of
boron trifluoride-methanol solution R. Boil under a reux
condenser for 10 min. Add 4 mL of heptane R through the
condenser. Boil under a reux condenser for 10 min. Allow to
cool. Add 20 mL of saturated sodium chloride solution R. Shake
and allow the layers to separate. Remove about 2 mL of the
organic layer and dry over 0.2 g of anhydrous sodium sulfate R.
Dilute 1.0 mL of the solution to 10.0 mL with heptane R.
Column
Time
(min)
0-2
Temperature
(C)
70
2 - 36
70 240
36 - 41
240
Injection port
220
Detector
260
Detection : ame ionisation.

Injection : 1 L.
Relative retention with reference to methyl stearate : methyl
palmitate = about 0.9.
System suitability : reference solution :
resolution : minimum 5.0 between the peaks due to methyl
palmitate and methyl stearate.
Calculate the content of palmitic acid and stearic acid.
Disregard the peak due to the solvent.
FUNCTIONALITY-RELATED CHARACTERISTICS
This section provides information on characteristics that are
recognised as being relevant control parameters for one or
more functions of the substance when used as an excipient (see
chapter 5.15). This section is a non-mandatory part of the
monograph and it is not necessary to verify the characteristics
to demonstrate compliance. Control of these characteristics can
however contribute to the quality of a medicinal product by
improving the consistency of the manufacturing process and
the performance of the medicinal product during use. Where
control methods are cited, they are recognised as being suitable
for the purpose, but other methods can also be used. Wherever
results for a particular characteristic are reported, the control
method must be indicated.
The following characteristics may be relevant for calcium
stearate used as a lubricant in tablets and capsules.
Particle-size distribution (2.9.31).
Specic surface area (2.9.26, Method I). Determine the
specic surface area in the P/Po range of 0.05 to 0.15.
Sample outgassing : 2 h at 40 C.
04/2009:0982
CALCIUM SULFATE DIHYDRATE

Calcii sulfas dihydricus
CaSO4,2H2O
[10101-41-4]
Mr 172.2
DEFINITION
Content : 98.0 per cent to 102.0 per cent of CaSO4,2H2O.
CHARACTERS
Appearance : white or almost white ne powder.
Solubility : very slightly soluble in water, practically insoluble
in ethanol (96 per cent).
Reference solution. Prepare the reference solution in the same

manner as the test solution using 50.0 mg of palmitic acid CRS
and 50.0 mg of stearic acid CRS instead of calcium stearate.
IDENTIFICATION
A. Loss on ignition (see Tests).
Column :
B. Solution S (see Tests) gives reaction (a) of sulfates (2.3.1).
material : fused silica ;
C. Solution S gives reaction (a) of calcium (2.3.1).
size : l = 30 m, = 0.32 mm ;
stationary phase : macrogol 20 000 R (lm thickness 0.5 m). TESTS
Solution S. Dissolve 1.0 g in 50 mL of a 10 per cent V/V
Carrier gas : helium for chromatography R.
solution of hydrochloric acid R by heating at 50 C for 5 min.
Flow rate : 2.4 mL/min.
Allow to cool.
General Notices (1) apply to all monographs and other texts
1751

Calcium Stearate

Uploaded by

Copyright:

Available Formats

Calcium Stearate

Uploaded by

Document Information

Original Description:

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Calcium Stearate

Uploaded by

Copyright:

Available Formats

Calcium stearate

Reference electrode : silver-silver chloride.

EUROPEAN PHARMACOPOEIA 8.0

See the information section on general monographs (cover pages)

Calcium sulfate dihydrate

EUROPEAN PHARMACOPOEIA 8.0

Lead : maximum 10 ppm.

Atomic absorption spectrometry (2.2.23, Method II).

Detection : ame ionisation.

CALCIUM SULFATE DIHYDRATE

Reference solution. Prepare the reference solution in the same

You might also like

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.